STAT6 and Hodgkins lymphoma: document the functional role of mutant STAT6 in maintaining tumor cell viability and show that genetic and functional mutations synergize with disruption of JAK-STAT pathway inhibitors to promote the growth of classical Hodgkin lymphoma (45).